3 Healthcare Stocks to Buy and Hold for the Next 10 Years

Stock Information for NervGen Pharma Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NervGen Pharma Corp.

2024 Cantech Letter Investment Conference Announces Presenting Companies and Exclusive Networking Events
WELL Health to Present at the 2024 Cantech Letter Conference in Toronto, ON
WELL Provides Corporate Update on Canadian Clinics Reflecting Strong Growth Momentum and Return on Invested Capital (ROIC) Performance
WELL Health's OceanMD and HEALWELL's Intrahealth Announce Partnership to Expand Access to eReferral Healthcare Solutions
WELL Health's Wisp Surpasses One Million Patients Served and $100M CAD in Runrate Revenues and Rolls out Ambitious Growth Plan
WELL Health Reports Record Results for Q2-2024 Driven by an Acceleration in Organic Growth and Raises Annual Guidance
WELL Health's Circle Medical Provides Corporate Update, Exceeds $100M USD Revenue Run Rate with Profitability and Positions for Further Growth
WELL Health to Announce Second Quarter 2024 Financial Results on August 14, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.